Stocks / Biotech

RLAYBiotech

Relay Therapeutics, Inc.
$19.761d +1.3%5d -5.2%settled close · 2026-08-24
Mkt cap $1.7B (8/16)β 2.1152w $11.81–21Shares 178.7MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2020Emp. 192HQ Cambridge, MArelaytx.com
Who’s talkingIdea Scout · free

Who’s talking about RLAY

No tracked investor commentary on RLAY yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
The options tape

Notable options days

Sessions in the last 120 where RLAY’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 8 of 120 sessions qualified.

The 5 most recent days are for Brief subscribers — the outcomes below are the free record.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-07-30
2026-07-29
2026-07-27
2026-06-02
2026-05-21
2026-05-20$13.183.6×$0M8.5%3.2%+22.5%
2026-05-19$11.812.8×$0M86.5%0.4%+31.8%
2026-05-18$12.712.4×$4M73.3%9.2%+18.4%
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on RLAY is in this morning’s Brief. Get The Brief — $20/mo →
Play history The Playbook · coming

Has a validated strategy ever fired on RLAY?

Has a validated strategy ever fired on RLAY — and how did the trades resolve? Even “never fired” is information.

Fire-by-fire history — play, entry, exit, result — is Playbook member content (coming).
FiredPlayEntry ExitResult
Every play carries a written validation gate, a spec, and a changelog. How plays are validated